-
at CNBC.com (Tue, 6:00PM)
-
at CNBC.com (Mon, 6:15PM)
-
at CNBC.com (May 9, 2013)
-
at CNBC.com (May 9, 2013)
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 7:39 PM Quintiles (Q) finshed its IPO debut today in the green, with the company’s shares ending the day at $42.11, up more than 5% from their initial offering price of $40. The company provides testing and diagnostic services to biopharmaceutical companies, and could see a boon to business with the implementation of President Obama’s health-care overhaul. Comment! [Healthcare, On the Move]
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.